Emily Kaiser Maharjan, Assistant Managing Editor

It's time for back-to-school eye exams, and host Miriam Korik, OD, teams up with Eyes Up host Damaris Raymondi, OD, FAAO, to chat about how to handle pediatric eye exams efficiently, thoroughly, and confidently.

Diabetic eye care expert A. Paul Chous, OD, MA, FAAO, shares insights on patient care and research.

Meeting attendees take courses on and engage in discourse on the field’s latest challenges.

Jessica Vaidya, OD, chose EVO ICL to correct her myopia and she shares her experience of being the patient with host Miriam Korik, OD. Dr Vaidya talks about her recovery experience, what the procedure felt like, and suggestions for eye care providers when discussion vision corrective surgery options with patients.

IKA Keratoconus Symposium and Controversies in Modern Eye Care shone brightly in May.

As part of the sports and performance vision section of the AOA, Vittorio Mena, OD, MS, shares information on how to bolster athletes' performance through enhanced vision care.

Derek Bryant, incoming AOSA president, is excited about the future of optometry and is dedicated to empowering students to lead and advocate for the profession.

Key steps include getting a new refraction, nailing the add power, and managing patient expectations.

Susan Gromacki, OD, MS, FAAO, FSLS, emphasizes the importance of leveraging modern technology and scientific advancements in contact lenses to provide the best possible comfort and vision correction for patients with astigmatism.

Nick Bruns, OD, FAAO, talks refractive surgery, from premium IOL options for patients with cataracts to EVO ICL for patients seeking elective corrective surgery.

Rafieetary emphasizes the importance of follow-up plans and consistent support to prevent patients from dropping out of treatment, which can negatively impact their prognosis.

Gromacki shares the importance of a dedicated approach to treating keratoconus, highlighting the need for passion, diverse tools, and a committed practice environment to ensure patient success.

Neurotech's ocular implant NT-501 utilizes encapsulated cell therapy to slow the progression of macular telangiectasia type 2 (MacTel). The implant was given a PDUFA goal date of December 17, 2024.

The rabbit model found that the levels of the active metabolites were very comparable, whether or not eyes had received a prior installation of perfluorohexyloctane.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Nazlee Zebardast, MD, MSc, overviews her 2 presentations from ARVO 2024 that utilized polygenic risk scores to identify patients' genetic risk of developing low risk for different glaucoma subtypes.

Aflibercept-jbvf and aflibercept-yszy are the first interchangeable biosimilars to aflibercept 2 mg that have been approved in the US.

William Reindel, OD, discusses how pupil size affects fit and comfort in multifocal contact lens wearers.

EyeCon chair Kelly K. Nichols, OD, PhD, MPH, FAAO, shares some of her favorite moments throughout her career and what inspires her to continue pushing the industry forward.

Catch up on what happened in optometry during the week of May 6-May 10.

Marjorie Rah, OD, PhD, FAAO, discussed the in-home use test of BioTrue Hydration Plus multipurpose contact lens solution (Bausch + Lomb) on patients who are considering lens dropout.

Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.

Andrew S. Morgenstern, OD, FAAO, FNAP, joins Dr. Korik to discuss a newly published study on the incidence of keratoconus among pediatric patients in a Chicago-based study. The pair also discuss the International Keratoconus Academy, and Morgenstern's experience working at Walter Reed Medical Center.

Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.

The manuscript, "Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama," highlights the burden of diabetic eye disease in Alabama, as well as strategies that target racial health disparities within that population.

Jill Saxon, OD, FAAO, chats about eye health safety for the upcoming total solar eclipse on April 8, 2024, and how Bausch + Lomb is celebrating the celestial event.

Davis Corley, CEO of Neurolens, outlines the importance a new study that show statistically significant improvement of headaches with the use of Neurolens.

One of the 15 clinics Miriam Korik, OD, works at is an optical boutique. She shares her expertise on exam personalization and how to realize these tweaks as sales.

March 23 is World Optometry Day, and we asked members of the optometric community one question: How does optometry make the world a better place?

The new model features stray light shielding, active micro-lens optics, improved power efficiency, and a scalable platform.